Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 376 - 400 of 1564 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Gangliosides LMSP0601AA07
  • GM4(d18:1/24:1(15Z))
  • NeuAcalpha2-3Galbeta-Cer(d18:1/24:1(15Z))
44261970 1100.769888 C59H108N2O16
Gangliosides LMSP0601AJ02
  • GM3(d18:1/18:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262037 84675 1180.744463 C59H108N2O21
Gangliosides LMSP0601DH03
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262614 1167.749214 C59H109NO21
Gangliosides LMSP0601AA05
  • GM4(d18:1/24:0)
  • NeuAcalpha2-3Galbeta-Cer(d18:1/24:0)
44261968 1102.785538 C59H110N2O16
Gangliosides LMSP0601AA08
  • GM4(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta-Cer(d18:1/26:1(17Z))
44261971 1128.801188 C61H112N2O16
Gangliosides LMSP0601AJ03
  • GM3(d18:1/20:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262038 84676 1208.775763 C61H112N2O21
Gangliosides LMSP0601DH04
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262615 1195.780514 C61H113NO21
Gangliosides LMSP0601AA06
  • GM4(d18:1/26:0)
  • NeuAcalpha2-3Galbeta-Cer(d18:1/26:0)
44261969 1130.816838 C61H114N2O16
Gangliosides LMSP0601DC01
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262572 1314.765988 C63H114N2O26
Gangliosides LMSP0601DG01
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • KDN-GM2(d18:1/16:0)
44262604 1314.765988 C63H114N2O26
Gangliosides LMSP0601DH07
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262618 1221.796164 C63H115NO21
Gangliosides LMSP0601AJ04
  • GM3(d18:1/22:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262039 84679 1236.807063 C63H116N2O21
Gangliosides LMSP0601DH05
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262616 1223.811814 C63H117NO21
Gangliosides LMSP0601AM01
  • GM2(d18:1/16:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262060 141459 1355.792537 C65H117N3O26
Gangliosides LMSP0601EK01
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262828 1355.792537 C65H117N3O26
Gangliosides LMSP0601CI01
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
52931289 1371.787452 C65H117N3O27
Gangliosides LMSP0601AJ07
  • GM3(d18:1/24:1(15Z))
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262042 84989 1262.822713 C65H118N2O21
Gangliosides LMSP0601DC02
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262573 1342.797288 C65H118N2O26
Gangliosides LMSP0601DG02
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • KDN-GM2(d18:1/18:0)
44262605 1342.797288 C65H118N2O26
Gangliosides LMSP0601DH08
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262619 1249.827464 C65H119NO21
Gangliosides LMSP0601AJ05
  • GM3(d18:1/24:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262040 84681 1264.838363 C65H120N2O21
Gangliosides LMSP0601DH06
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262617 1251.843114 C65H121NO21
Gangliosides LMSP0601AP01
  • GM1(d18:1/12:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/12:0)
44262084 1461.782762 C67H119N3O31
Gangliosides LMSP0601AM02
  • GM2(d18:1/18:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262061 60327 1383.823837 C67H121N3O26
Gangliosides LMSP0601EK02
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262829 1383.823837 C67H121N3O26

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024